Subscribe by Email

About the Blog

The Active Ingredient features expert insights and commentary from leaders of ZS Associates' global pharmaceuticals practice.

Search by Topic

see all

Four Takeaways From the Year’s Biggest—and Rainiest—Healthcare Conference

Posted by Ann Klein on Thu, Jan 31, 2019

Every year in early January, Union Square in San Francisco transforms from a shopping mecca to a (usually rainy) gathering of leadership teams from payers, large providers, life sciences companies and tech companies across the globe. The visual is dramatic: You’ll never see as many dark suits in San Francisco than when you’re wandering around town during the JPMorgan Healthcare Conference.

Read More

Topics: Pharma, Pharma Industry, Life Sciences, Google, JPMorgan Chase, health technology, JPMorgan Healthcare Conference, JPM2019, san francisco, software, Uber Health, health innovation

What’s ‘BerkshAmazMorgan’ Really Capable Of?

Posted by Howard Deutsch on Tue, Feb 20, 2018

Bill Coyle, Paul Darling and Pratap Khedkar co-authored this post with Howard Deutsch.

This is the first post in a two-part series on the recently announced Berkshire Hathaway/Amazon/JPMorgan Chase healthcare venture. 

Look! Out in the distance! What’s that creature that’s destroying everything in its path? Why, it’s the scariest three-headed monster this side of Cerberus! It’s… it’s… it’s BerkshAmazMorgan! Will any of us be safe from this dreaded, rampaging beast?

Read More

Topics: Bill Coyle, Pratap Khedkar, Health Outcomes, healthcare, vertical integration, healthcare ecosystem, Paul Darling, Howard Deutsch, Amazon, collaboration, Berkshire Hathaway, JPMorgan Chase, corporatization, BerkshAmazMorgan, employees, healthcare costs

Subscribe to The Active Ingredient
SUBSCRIBE

Get 'THE ACTIVE INGREDIENT' Updates

Subscribe to receive email notifications whenever new blog posts are published.

×